Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

TriSalus Life Sciences, Inc. (TLSI) vs Viemed Healthcare, Inc. (VMD)

TriSalus Life Sciences, Inc. and Viemed Healthcare, Inc. are both Medical Devices companies. Viemed Healthcare, Inc. is the larger, with a market value of $335.9M against $303.6M — 1.1× the size. TriSalus Life Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Viemed Healthcare, Inc. trades at 23.4×. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 25.2%. Viemed Healthcare, Inc. has the higher net margin (4.81% vs −127.0%) and the higher return on invested capital (10.7% vs 0.00%). Across the 18 metrics below, Viemed Healthcare, Inc. leads on 12 and TriSalus Life Sciences, Inc. on 6.

Valuation

Metric TLSI VMD Medical Devices median
P/E n/m 23.45 22.18
P/S 5.61 1.13 2.70
P/B 38.63 2.33 2.46
Price to free cash flow n/m 9.90 22.53
EV/EBITDA n/m 6.15 11.78
EV/Sales 5.33 1.12 2.38
Earnings yield (29.95%) 4.26% (8.22%)
Free cash flow yield (9.48%) 10.10% (7.80%)

Profitability

Metric TLSI VMD Medical Devices median
Gross margin 85.79% 57.47% 56.01%
Operating margin (67.68%) 8.05% (15.03%)
Net margin (127.00%) 4.81% (20.40%)
Free cash flow margin (51.56%) 11.42% (7.24%)
Return on equity 889.44% 10.08% (15.32%)
Return on assets (110.34%) 7.46% (19.72%)
Return on invested capital 0.00% 10.66% (10.33%)

Growth

Metric TLSI VMD Medical Devices median
Revenue growth (TTM) 25.25% 25.21% 8.80%
EPS growth (last fiscal year) (40.46%) 32.14% —
Revenue growth, 5-year CAGR — 15.53% 15.23%
Net income growth, 5-year CAGR 0.00% (13.88%) 0.00%

Health

Metric TLSI VMD Medical Devices median
Debt to equity 5.05 0.05 0.07
Current ratio 5.35 1.13 2.50
Net debt to EBITDA (0.50) (0.02) 0.49

Dividend

Metric TLSI VMD Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric TLSI VMD Medical Devices median
Market cap 303.56m 335.94m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack